Bio-Techne Corporation (TECH) Balance Sheet
TECH balance sheet, FY2026
June 30, 2026 · U.S. dollars$2.68B assets = $570.8M liabilities + $2.11B equity
Both columns are drawn to the same scale: what TECH owns equals what it owes plus shareholders’ equity. Hover a block for its value.
TECH financial health
Current ratio4.55
Comfortable · current assets cover current liabilities 4.55×
Debt / equity0.14
Low leverage · $0.14 of debt for each $1 of equity
Equity / assets78.7%
Equity-funded · of assets funded by shareholders
Cash / debt91.6%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles47.7%
Acquisition-heavy · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
TECH balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.56BFY2017 | $2.68BFY2026 | +6.2%/yr | |
| Total liabilities | $605.8MFY2017 | $570.8MFY2026 | −0.7%/yr | |
| Shareholders’ equity | $950.8MFY2017 | $2.11BFY2026 | +9.3%/yr | |
| Cash & short-term investments | $157.7MFY2017 | $264.7MFY2026 | +5.9%/yr | |
| Total debt | $349.9MFY2017 | $289.1MFY2026 | −2.1%/yr | |
| Net cash (debt) | −$192.2MFY2017 | −$24.4MFY2026 | +$167.8M | |
| Working capital | $209.9MFY2017 | $580.7MFY2026 | +$370.8M | |
| Book value per share | $6.34FY2017 | $13.43FY2026 | +8.7%/yr | |
| Current ratio | 2.55FY2017 | 4.55FY2026 | +2.00 | |
| Debt / equity | 0.37FY2017 | 0.14FY2026 | −0.23 | |
| Shares outstanding | 150.0MFY2017 | 157.0MFY2026 | +0.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
TECH assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
TECH liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
TECH debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
TECH balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $264.7M | $162.2M | $152.9M | $204.3M | $247.0M | $231.6M | $270.9M | $166.0M | $181.8M | $157.7M |
| Cash & equivalents | $264.7M | $162.2M | $151.8M | $180.6M | $172.6M | $199.1M | $146.6M | $100.9M | $122.0M | $91.6M |
| Short-term investments | — | $0 | $1.1M | $23.7M | $74.5M | $32.5M | $124.3M | $65.1M | $59.8M | $66.1M |
| Receivables | $220.5M | $206.9M | $241.4M | $218.5M | $194.5M | $145.4M | $122.5M | $137.5M | $120.3M | $116.8M |
| Inventory | $195.7M | $189.4M | $179.7M | $171.6M | $141.1M | $116.7M | $103.2M | $91.0M | $85.6M | $60.2M |
| Other current assets | $63.4M | $49.8M | $43.4M | $27.1M | $22.9M | $16.9M | $24.3M | $18.1M | $10.7M | $10.6M |
| Total current assets | $744.4M | $608.3M | $617.4M | $621.5M | $605.6M | $510.6M | $520.9M | $412.6M | $398.4M | $345.3M |
| Property, plant & equipment (net) | $299.2M | $319.1M | $342.4M | $324.5M | $288.8M | $281.7M | $248.3M | $154.0M | $145.3M | $135.1M |
| Goodwill & intangible assets | $1.28B | $1.35B | $1.48B | $1.41B | $1.35B | $1.46B | $1.24B | $1.31B | $1.04B | $1.03B |
| Long-term investments | $245.8M | $251.0M | $242.3M | $255.9M | $25.0M | $0 | $0 | $0 | $2.7M | $40.4M |
| Other non-current assets | $110.8M | $32.9M | $21.9M | $29.4M | $21.8M | $11.6M | $13.5M | $5.7M | $2.6M | $4.8M |
| Total assets | $2.68B | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B | $1.88B | $1.59B | $1.56B |
| Liabilities | ||||||||||
| Accounts payable | $26.7M | $25.3M | $38.0M | $25.7M | $33.9M | $29.4M | $23.1M | $16.2M | $63.6M | $16.9M |
| Short-term debt | $14.9M | $14.1M | $12.9M | $11.2M | $24.4M | $24.1M | $22.0M | $12.5M | $8.9M | $6.1M |
| Deferred revenue | $36.1M | $32.6M | $27.9M | $23.1M | $23.4M | $19.0M | $13.0M | $9.1M | $7.1M | $6.0M |
| Total current liabilities | $163.7M | $175.8M | $159.4M | $128.5M | $176.0M | $152.3M | $106.7M | $102.0M | $78.7M | $135.4M |
| Long-term debt | $200.0M | $346.0M | $319.0M | $350.0M | $243.4M | $328.8M | $344.2M | $492.7M | $339.0M | $343.8M |
| Lease obligations | $89.1M | $98.1M | $100.5M | $105.0M | $70.1M | $79.2M | $76.8M | — | — | — |
| Other long-term liabilities | $207.1M | $117.2M | $156.6M | $193.7M | $174.4M | $210.6M | $195.5M | $124.2M | $96.4M | $126.7M |
| Total liabilities | $570.8M | $639.1M | $635.0M | $672.2M | $593.8M | $691.7M | $646.4M | $718.8M | $514.1M | $605.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $390,000 | $385,000 | $379,000 | $376,000 | $374,000 |
| Retained earnings (deficit) | $1.14B | $1.07B | $1.33B | $1.31B | $1.12B | $1.09B | $1.06B | $931.9M | $876.9M | $799.0M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$70.6M | −$59.9M | −$78.3M | −$66.1M | −$75.2M | −$57.3M | −$97.2M | −$83.5M | −$44.8M | −$48.9M |
| Minority interest | — | $0 | $0 | $0 | −$759,000 | $8.3M | — | — | $0 | $0 |
| Total shareholders' equity | $2.11B | $1.92B | $2.07B | $1.97B | $1.70B | $1.56B | $1.38B | $1.17B | $1.08B | $950.8M |
| Key figures | ||||||||||
| Total debt | $289.1M | $444.1M | $419.5M | $455.0M | $326.0M | $420.6M | $433.5M | $505.2M | $347.9M | $349.9M |
| Net cash (debt) | −$24.4M | −$281.9M | −$266.7M | −$250.7M | −$78.9M | −$189.0M | −$162.6M | −$339.1M | −$166.1M | −$192.2M |
| Working capital | $580.7M | $432.5M | $458.0M | $493.0M | $429.5M | $358.3M | $414.3M | $310.6M | $319.7M | $209.9M |
| Tangible book value | $829.4M | $572.3M | $589.1M | $559.1M | $348.1M | $103.9M | $136.3M | −$146.5M | $34.9M | −$80.2M |
| Book value per share | $13.43 | $12.01 | $12.87 | $12.15 | $10.37 | $9.65 | $8.76 | $7.49 | $7.09 | $6.34 |
| Shares outstanding | 157.0M | 159.7M | 160.8M | 161.9M | 164.1M | 161.9M | 157.6M | 155.6M | 152.2M | 150.0M |
| Current ratio | 4.55 | 3.46 | 3.87 | 4.84 | 3.44 | 3.35 | 4.88 | 4.05 | 5.06 | 2.55 |
| Quick ratio | 2.96 | 2.10 | 2.47 | 3.29 | 2.51 | 2.48 | 3.69 | 2.98 | 3.84 | 2.03 |
| Debt / equity | 0.14 | 0.23 | 0.20 | 0.23 | 0.19 | 0.27 | 0.31 | 0.43 | 0.32 | 0.37 |
| Equity / assets | 78.7% | 75.0% | 76.5% | 74.5% | 74.2% | 69.1% | 68.1% | 61.9% | 67.7% | 61.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $264.7M | $209.8M | $172.9M | $145.0M | $162.2M | $140.7M | $177.5M | $187.5M | $152.9M | $145.3M | $135.7M | $148.7M |
| Cash & equivalents | $264.7M | $209.8M | $172.9M | $145.0M | $162.2M | $140.7M | $177.5M | $187.5M | $151.8M | $139.9M | $130.1M | $148.7M |
| Short-term investments | — | — | — | — | $0 | $0 | $0 | $0 | $1.1M | $5.4M | $5.5M | $0 |
| Receivables | $216.6M | $217.9M | $184.6M | $183.9M | $206.9M | $237.1M | $217.9M | $223.7M | $241.4M | $227.9M | $207.5M | $204.6M |
| Inventory | $195.7M | $201.2M | $205.4M | $203.2M | $189.4M | $191.1M | $188.4M | $185.0M | $179.7M | $179.5M | $180.8M | $186.1M |
| Other current assets | $67.4M | $59.1M | $74.5M | $77.5M | $49.8M | $58.3M | $50.8M | $52.3M | $43.4M | $58.0M | $66.7M | $52.2M |
| Total current assets | $744.4M | $688.0M | $637.4M | $609.5M | $608.3M | $627.2M | $634.6M | $648.6M | $617.4M | $610.6M | $590.6M | $591.5M |
| Property, plant & equipment (net) | $299.2M | $301.3M | $302.6M | $311.1M | $319.1M | $335.8M | $335.1M | $343.2M | $342.4M | $341.0M | $335.1M | $334.0M |
| Goodwill & intangible assets | $1.28B | $1.30B | $1.32B | $1.33B | $1.35B | $1.41B | $1.43B | $1.47B | $1.48B | $1.50B | $1.53B | $1.55B |
| Long-term investments | $245.8M | $246.0M | $250.0M | $258.6M | $251.0M | $254.5M | $256.4M | $256.3M | $242.3M | $248.0M | $249.7M | $251.6M |
| Other non-current assets | $18.5M | $18.3M | $17.0M | $18.0M | $32.9M | $14.4M | $18.6M | $19.4M | $21.9M | $24.2M | $24.6M | $29.9M |
| Total assets | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B | $2.72B | $2.73B | $2.76B |
| Liabilities | ||||||||||||
| Accounts payable | $105.1M | $23.5M | $26.3M | $30.2M | $25.3M | $31.6M | $33.1M | $31.6M | $38.0M | $28.9M | $31.5M | $28.1M |
| Short-term debt | $14.9M | $14.2M | $13.7M | $13.8M | $14.1M | $14.0M | $13.5M | $13.5M | $12.9M | $13.0M | $12.7M | $12.2M |
| Deferred revenue | $36.1M | $38.4M | $31.0M | $30.4M | $32.6M | $32.3M | $27.7M | $26.6M | $27.9M | $30.1M | $28.4M | $24.5M |
| Total current liabilities | $163.7M | $153.3M | $140.4M | $144.5M | $175.8M | $169.2M | $161.3M | $142.1M | $159.4M | $149.8M | $135.2M | $127.8M |
| Long-term debt | $200.0M | $200.0M | $260.0M | $300.0M | $346.0M | $330.0M | $300.0M | $300.0M | $319.0M | $389.0M | $447.0M | $440.0M |
| Lease obligations | $89.1M | $90.3M | $90.9M | $94.5M | $98.1M | $93.5M | $95.1M | $98.9M | $100.5M | $105.7M | $108.7M | $109.5M |
| Other long-term liabilities | $114.8M | $112.0M | $111.3M | $115.8M | $117.2M | $127.0M | $130.7M | $155.2M | $156.6M | $168.0M | $185.0M | $189.9M |
| Total liabilities | $478.5M | $465.3M | $511.7M | $560.3M | $639.1M | $626.2M | $591.9M | $597.4M | $635.0M | $706.8M | $767.2M | $757.6M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M |
| Retained earnings (deficit) | $1.14B | $1.15B | $1.11B | $1.08B | $1.07B | $1.20B | $1.29B | $1.34B | $1.33B | $1.30B | $1.26B | $1.33B |
| Accumulated other comprehensive income | −$70.6M | −$66.9M | −$62.3M | −$64.4M | −$59.9M | −$82.1M | −$85.7M | −$60.1M | −$78.3M | −$75.3M | −$63.7M | −$78.0M |
| Minority interest | — | — | — | — | $0 | — | — | — | — | — | — | — |
| Total shareholders' equity | $2.11B | $2.09B | $2.01B | $1.97B | $1.92B | $2.02B | $2.08B | $2.14B | $2.07B | $2.01B | $1.96B | $2.00B |
| Key figures | ||||||||||||
| Total debt | $289.1M | $290.3M | $350.9M | $394.5M | $444.1M | $423.5M | $395.1M | $398.9M | $419.5M | $494.7M | $555.7M | $549.5M |
| Net cash (debt) | −$24.4M | −$80.5M | −$178.0M | −$249.5M | −$281.9M | −$282.8M | −$217.6M | −$211.4M | −$266.7M | −$349.4M | −$420.0M | −$400.9M |
| Working capital | $580.7M | $534.8M | $497.0M | $465.0M | $432.5M | $458.0M | $473.4M | $506.4M | $458.0M | $460.8M | $455.4M | $463.7M |
| Tangible book value | $829.4M | $788.4M | $695.4M | $636.8M | $572.3M | $605.7M | $652.8M | $670.1M | $589.1M | $517.0M | $432.9M | $449.4M |
| Book value per share | $13.43 | $13.29 | $12.81 | $12.57 | $12.32 | $12.70 | $12.94 | $13.27 | $12.88 | $12.55 | $12.27 | $12.34 |
| Shares outstanding | 157.0M | 156.9M | 157.0M | 156.4M | 155.8M | 158.9M | 160.6M | 161.1M | 160.7M | 160.5M | 160.1M | 161.9M |
| Current ratio | 4.55 | 4.49 | 4.54 | 4.22 | 3.46 | 3.71 | 3.94 | 4.56 | 3.87 | 4.08 | 4.37 | 4.63 |
| Quick ratio | 2.94 | 2.79 | 2.55 | 2.28 | 2.10 | 2.23 | 2.45 | 2.89 | 2.47 | 2.49 | 2.54 | 2.76 |
| Debt / equity | 0.14 | 0.14 | 0.17 | 0.20 | 0.23 | 0.21 | 0.19 | 0.19 | 0.20 | 0.25 | 0.28 | 0.28 |
| Equity / assets | 81.5% | 81.8% | 79.7% | 77.8% | 75.0% | 76.3% | 77.8% | 78.2% | 76.5% | 74.0% | 71.9% | 72.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 24, 2026); data from EODHD.
TECH financial position
At the end of fiscal 2026 (June 30, 2026), Bio-Techne had total assets of $2.7 billion (up 4.7% from a year earlier), total liabilities of $570.8 million and shareholders' equity of $2.1 billion. It held $264.7 million in cash and short-term investments against $289.1 million of debt, net debt of $24.4 million. Its current ratio was 4.55.
Related: TECH income statement, TECH cash flow statement, TECH key metrics. See the TECH stock overview for the latest quote and news.
TECH balance sheet FAQ
What are Bio-Techne's total assets?
Bio-Techne reported total assets of $2.7 billion at the end of fiscal 2026 (June 30, 2026), compared with $2.6 billion a year earlier.
How much debt does Bio-Techne have?
Bio-Techne had $289.1 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.14.
How much cash does Bio-Techne have?
Bio-Techne held $264.7 million in cash and short-term investments at the end of fiscal 2026; with $289.1 million of debt that is net debt of $24.4 million.
What is Bio-Techne's book value?
Bio-Techne's shareholders' equity (book value) was $2.1 billion at the end of fiscal 2026, or $13.43 per share.
What is Bio-Techne's current ratio?
Bio-Techne had current assets of $744.4 million and current liabilities of $163.7 million, a current ratio of 4.55 (it can cover its short-term obligations).
How much goodwill does Bio-Techne have?
Bio-Techne carried $1.3 billion of goodwill and intangible assets, 47.7% of total assets, at the end of fiscal 2026.